Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
dc.contributor.author | Taylor, Sally | |
dc.contributor.author | Tsim, S | |
dc.contributor.author | Navani, N | |
dc.contributor.author | Baldwin, D | |
dc.contributor.author | Woolhouse, I | |
dc.contributor.author | Edwards, J | |
dc.contributor.author | Grundy, S | |
dc.contributor.author | Robson, J | |
dc.contributor.author | Rhodes, S | |
dc.contributor.author | Burnside, N | |
dc.contributor.author | Blackhall, Fiona H | |
dc.contributor.author | Faivre-Finn, Corinne | |
dc.contributor.author | Yorke, Janelle | |
dc.contributor.author | Evison, M | |
dc.date.accessioned | 2022-05-04T08:42:01Z | |
dc.date.available | 2022-05-04T08:42:01Z | |
dc.date.issued | 2021-07 | |
dc.identifier.citation | Taylor, Sally, Tsim, S ,Navani, N, Baldwin, D, Woolhouse, I, Edwards, J, Grundy, S, Robson, J, Rhodes, S Burnside, N, Blackhall, Fiona H,Faivre-Finn, Corinne, Yorke, Janelle, Evison, M. Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial) Lung Cancer. 2022 Jul; 8(1): e000846. | en_US |
dc.identifier.pmid | 34266853 | |
dc.identifier.doi | 10.1136/bmjresp-2020-000846 | |
dc.identifier.uri | http://hdl.handle.net/10541/625194 | |
dc.language.iso | en | en_US |
dc.relation.url | https://dx.doi.org/10.1136/bmjresp-2020-000846 | en_US |
dc.title | Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial) | en_US |
dc.type | Article | en_US |
dc.contributor.department | Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK | en_US |
dc.identifier.journal | Lung Cancer | en_US |